Gara Jalqabaatti › Cufama Onnee › California › San Francisco
Qorannoo klinikaalii Cufama Onnee San Francisco, CA keessatti
Qorannoo 29 Cufama Onnee f San Francisco fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
ELEVATE-HFpEF Clinical Study
Namoota walitti qabaa jira
- Sutter Health Hospital, San Francisco
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, San Francisco
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Namoota walitti qabaa jiraSadarkaa 2
- University of California, San Francisco, San Francisco
- University of California San Francisco UCSF, San Francisco
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Namoota walitti qabaa jiraSadarkaa 3
- California Pacific Medical Center Van Ness Campus, San Francisco
Alleviant ALLAY-HFrEF Study
Namoota walitti qabaa jira
- University of California San Francisco, San Francisco
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Kaiser Permanente, San Francisco
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, San Francisco
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Namoota walitti qabaa jiraSadarkaa 3
- San Francisco, CA Investigative Site CON-10315, San Francisco
- CON-10023, San Francisco, CA, San Francisco
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Namoota walitti qabaa jiraSadarkaa 3
- San Francisco, CA Investigative Site 10023, San Francisco
Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure
Namoota walitti qabaa jira
- University of California, San Francisco, San Francisco
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Namoota walitti qabaa jiraSadarkaa 2
- University of California, San Francisco - Heart and Vascular Center, San Francisco
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Namoota walitti qabaa jira
- Zuckerberg San Francisco General, San Francisco
- University of California San Francisco, San Francisco
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Namoota walitti qabaa jiraQorannoo ilaalaa
- University Of California San Francisco Medical Center, San Francisco
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Namoota walitti qabaa jiraSadarkaa 3
- Tenax Investigational Site, San Francisco
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Kaiser Permanente Northern California, San Francisco
- San Francisco V.A. Medical Center, San Francisco
Alleviant ALLAY-HF Study
Namoota walitti qabaa jira
- University of California San Francisco, San Francisco
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Namoota walitti qabaa jiraSadarkaa 3
- UC San Francisco Medical Center, San Francisco
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Namoota walitti qabaa jiraSadarkaa 3
- San Francisco, CA Investigative Site FIN-10023, San Francisco
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Namoota walitti qabaa jira
- UCSF Medical Center, San Francisco
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Namoota walitti qabaa jira
- University of California at San Francisco, San Francisco
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Namoota walitti qabaa jiraSadarkaa 3
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
Developing a Digital Aid to Improve ICD Decisions
Namoota walitti qabaa jira
- University of California, San Francisco, San Francisco
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Namoota walitti qabaa jira
- University of California- San Francisco, San Francisco
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of California, San Francisco (UCSF), San Francisco
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Namoota walitti qabaa jiraQorannoo ilaalaa
- UCSF, San Francisco
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of California, San Francisco, San Francisco
- Kaiser Permanente San Francisco, San Francisco
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Namoota walitti qabaa jiraSadarkaa 1
- University of California San Francisco, San Francisco
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of California San Francisco, San Francisco
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Namoota walitti qabaa jiraSadarkaa 1/2
- University of California, San Francisco, San Francisco
Qorannoo Cufama Onnee magaalota biroo keessatti
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Dallas, TXQorannoo 42
- Houston, TXQorannoo 36
- Cleveland, OHQorannoo 33
- Chicago, ILQorannoo 31
- Philadelphia, PAQorannoo 31
- St. Louis, MOQorannoo 26
- Durham, NCQorannoo 26
- Atlanta, GAQorannoo 25
- Kansas City, MOQorannoo 25
- Baltimore, MDQorannoo 24
Qorannoo biroo San Francisco keessatti
- Kansarii ProstateQorannoo 45
- Saree OljooQorannoo 43
- Kansara Qara'a Non-Small CellQorannoo 36
- Saree (Gosoota Hunda)Qorannoo 35
- Kansara MetastatikiiQorannoo 28
- Dhibee QaraQorannoo 23
- MelanomaQorannoo 22
- Kansarii PancreasQorannoo 20
- Kansarii OvariiQorannoo 19
- Kansarii ColorectalQorannoo 18
- Dhibee Onneessaa fi DhiigaQorannoo 18
- GlioblastomaQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.